Cargando…
A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy
There is increasing evidence that novel coronavirus disease 2019 (COVID-19) leads to a significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy”. COVID-19 has been associated with increased rates of both venous and arterial thromboembolic events, a source of significant morbid...
Autores principales: | Goswami, Julie, MacArthur, Taleen A., Sridharan, Meera, Pruthi, Rajiv K., McBane, Robert D., Witzig, Thomas E., Park, Myung S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122038/ https://www.ncbi.nlm.nih.gov/pubmed/33378321 http://dx.doi.org/10.1097/SHK.0000000000001680 |
Ejemplares similares
-
In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023) -
Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19–Positive Compared With COVID-19–Negative Patients
por: Chaudhary, Rahul, et al.
Publicado: (2021) -
P1616: EMICIZUMAB FOR THE MANAGEMENT OF ACQUIRED HEMOPHILIA A
por: Sridharan, Meera, et al.
Publicado: (2023) -
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19
por: Pasha, Ahmed K., et al.
Publicado: (2021) -
No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2022)